×
About 270 results

ALLMedicine™ Breast Cancer Guidelines Center

Research & Reviews  53 results

Receipt of guideline-concordant care among young adult women with breast cancer.
https://doi.org/10.1002/cncr.33652
Cancer White DP, Kurian AW et. al.

Jun 1st, 2021 - Little is known about the real-world care of young adult (YA) females (aged 20-39 years) with breast cancer. This study describes factors associated with the receipt of guideline-concordant care (GCC) among YAs. The authors identified 1259 YA wome...

Adherence to breast cancer guidelines is associated with better survival outcomes: a sy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542898
BMC Health Services Research; Ricci-Cabello I, Vásquez-Mejía A et. al.

Oct 8th, 2020 - Breast cancer (BC) clinical guidelines offer evidence-based recommendations to improve quality of healthcare for patients with or at risk of BC. Suboptimal adherence to recommendations has the potential to negatively affect population health. Howe...

Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592930
Public Health Genomics; Augustinsson A, Ellberg C et. al.

Jul 8th, 2020 - Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC) at the age of 35 years or younger should be referred to their regional oncogenetic clinic for genetic counseling and testing, regardless of family...

Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic lit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220981
Breast Cancer Research and Treatment; Niño de Guzmán E, Song Y et. al.

May 7th, 2020 - Clinical guidelines' (CGs) adherence supports high-quality care. However, healthcare providers do not always comply with CGs recommendations. This systematic literature review aims to assess the extent of healthcare providers' adherence to breast ...

Breast reconstruction after therapeutic or prophylactic mastectomy for breast cancer: A...
https://doi.org/10.1016/j.ejso.2020.01.024
European Journal of Surgical Oncology : the Journal of Th... Popowich B, Kostaras X et. al.

Feb 14th, 2020 - The purpose of this article is to illuminate differences in published clinical practice guideline recommendations for breast reconstruction after prophylactic and therapeutic mastectomy. Ten guidelines were identified through a systematic search o...

see more →

Guidelines  65 results

Breast Cancer: Medication Use to Reduce Risk- Draft Recommendation Statement
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/breast-cancer-medications-for-risk-reduction1
USPSTF

Jan 14th, 2019 - The USPSTF concludes with moderate certainty that there is a moderate net benefit from taking tamoxifen, raloxifene, or aromatase inhibitors to reduce risk of invasive breast cancer in women at increased risk. The USPSTF concludes with moderate ce...

Radiation therapy for the whole breast: Executive summary of an American Society for Radiati...
https://www.practicalradonc.org/article/S1879-8500(18)30051-1/abstract?code=prro-site
Benjamin D. Smith

May 31st, 2018 - This guideline will replace the original ASTRO guideline on this topic that was published in 2011 in light of the considerable new evidence that has accumulated in the intervening years. The guideline will cover five key questions regarding whole.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/16/3/310.full
Gradishar, W

Feb 28th, 2018 - Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer.

Role of Bone-Modifying Agents in Metastatic Breast Cancer Update
http://ascopubs.org/doi/full/10.1200/JCO.2017.75.4614
Catherine Van Poznak

Dec 9th, 2017 - To update, in collaboration with Cancer Care Ontario (CCO), key recommendations of the American Society of Clinical Oncology (ASCO) guideline on the role of bone-modifying agents (BMAs) in metastatic breast cancer. This focused update addressed th.

Practice Advisory: Hormonal Contraception and Risk of Breast Cancer
https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Hormonal-Contraception-and-Risk-of-Breast-Cancer

Dec 6th, 2017 - On December 7, 2017, a cohort study analyzing the risk of invasive breast cancer in women who used hormonal contraception was published in the New England Journal of Medicine (1). The study was designed to assess the influence of hormonal contrace.

see more →

Clinicaltrials.gov  137 results

Receipt of guideline-concordant care among young adult women with breast cancer.
https://doi.org/10.1002/cncr.33652
Cancer White DP, Kurian AW et. al.

Jun 1st, 2021 - Little is known about the real-world care of young adult (YA) females (aged 20-39 years) with breast cancer. This study describes factors associated with the receipt of guideline-concordant care (GCC) among YAs. The authors identified 1259 YA wome...

Adherence to breast cancer guidelines is associated with better survival outcomes: a sy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542898
BMC Health Services Research; Ricci-Cabello I, Vásquez-Mejía A et. al.

Oct 8th, 2020 - Breast cancer (BC) clinical guidelines offer evidence-based recommendations to improve quality of healthcare for patients with or at risk of BC. Suboptimal adherence to recommendations has the potential to negatively affect population health. Howe...

Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592930
Public Health Genomics; Augustinsson A, Ellberg C et. al.

Jul 8th, 2020 - Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC) at the age of 35 years or younger should be referred to their regional oncogenetic clinic for genetic counseling and testing, regardless of family...

Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic lit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220981
Breast Cancer Research and Treatment; Niño de Guzmán E, Song Y et. al.

May 7th, 2020 - Clinical guidelines' (CGs) adherence supports high-quality care. However, healthcare providers do not always comply with CGs recommendations. This systematic literature review aims to assess the extent of healthcare providers' adherence to breast ...

ESMO Gets Creative With Guidelines for Breast Cancer Care in the COVID-19 Era
https://www.medscape.com/viewarticle/929703

Apr 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ESMO's breast cancer guidelines expand upon guidelines issued by other groups, addressing a broad spectrum of patient profiles and providing a cre...

see more →

News  15 results

ESMO Gets Creative With Guidelines for Breast Cancer Care in the COVID-19 Era
https://www.medscape.com/viewarticle/929703

Apr 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ESMO's breast cancer guidelines expand upon guidelines issued by other groups, addressing a broad spectrum of patient profiles and providing a cre...

Breast Cancer: Medication Use to Reduce Risk- Draft Recommendation Statement
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/breast-cancer-medications-for-risk-reduction1
USPSTF

Jan 14th, 2019 - The USPSTF concludes with moderate certainty that there is a moderate net benefit from taking tamoxifen, raloxifene, or aromatase inhibitors to reduce risk of invasive breast cancer in women at increased risk. The USPSTF concludes with moderate ce...

Breast Cancer Guidelines Outlook Covers Radiotherapy, Biomarkers, and More
https://www.onclive.com/publications/oncology-live/2017/vol-18-no-11/breast-cancer-guidelines-outlook-covers-radiotherapy-biomarkers-and-more

May 28th, 2017 - Kilian E. Salerno, MD Updated guidelines for the management of invasive breast cancer, issued by the National Comprehensive Cancer Network (NCCN), define indications for radiation therapy, the use of biomarkers and multigene assays in clinical dec...

NCCN fine-tunes breast cancer guidelines
https://www.mdedge.com/familymedicine/article/107845/breast-cancer/nccn-fine-tunes-breast-cancer-guidelines/page/0/1
Internal Medicine News;

Apr 5th, 2016 - For patients with recurrent HER2-positve disease with prior trastuzumab exposure, combinations may include lapatinin with capecitabine, or trastuzumab with capecitabine, lapatinib (without cytoxic therapy), or other agents. Fertility preservation.

Breast Cancer Guidelines Compared: ESMO vs NCCN
https://www.medscape.com/viewarticle/842897

Apr 8th, 2015 - A comparison of breast cancer guidelines from two of the world's most prominent oncology organizations, the National Comprehensive Cancer Network (NCCN) and the European Society of Medical Oncology (ESMO), has revealed "substantial concordance," b...

see more →